Anders Bjartell
211 – 220 of 345
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
Evaluation of Multiple Risk-Associated Single Nucleotide Polymorphisms Versus Prostate-Specific Antigen at Baseline to Predict Prostate Cancer in Unscreened Men
(
- Contribution to journal › Article
-
Mark
A Compartmental Model for Biokinetics and Dosimetry of 18F-Choline in Prostate Cancer Patients
(
- Contribution to journal › Article
-
Mark
Dietary intakes of carbohydrates in relation to prostate cancer risk: a prospective study in the Malmo Diet and Cancer cohort.
(
- Contribution to journal › Article
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
- 2011
-
Mark
Epigenetics in Prostate Cancer: Biologic and Clinical Relevance
(
- Contribution to journal › Article
-
Mark
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
(
- Contribution to journal › Scientific review
-
Mark
Tumor markers in prostate cancer I: Blood-based markers
(
- Contribution to journal › Scientific review
-
Mark
Tumour markers in prostate cancer III: Biomarkers in urine
(
- Contribution to journal › Scientific review
-
Mark
Role of histopathology and molecular markers in the active surveillance of prostate cancer
(
- Contribution to journal › Scientific review
-
Mark
Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis.
2011) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 24. p.708-719(
- Contribution to journal › Article